Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cell membrane and endocytic uptake machinery represent the collective biological structures and processes responsible for the internalization of extracellular substances into recipient cells. This system includes the plasma membrane's lipid bilayer and a diverse array of proteins that facilitate pathways such as clathrin-mediated endocytosis, caveolae-mediated endocytosis, macropinocytosis, and phagocytosis (Nature Reviews Molecular Cell Biology, 2018). While not a single molecular target, this machinery is the primary gateway for the delivery of advanced therapeutics, including nanoparticles, exosomes, and viral vectors (Journal of Controlled Release, 2021). Many pathogens, such as SARS-CoV-2 and influenza viruses, exploit these pathways to gain entry into host cells, making the components of this machinery relevant in infectious disease research (Annual Review of Virology, 2014). Pharmacological modulation of these pathways is often used in research to study cargo entry, but therapeutic application is limited by the essential role these processes play in maintaining cellular homeostasis across all tissues (Nature Communications, 2019). Specific proteins within this machinery, such as dynamin or clathrin, can be targeted by small molecules like dynasore or chlorpromazine to inhibit uptake, though these often lack the specificity required for clinical use (Frontiers in Pharmacology, 2021). The complexity of these pathways, involving numerous protein-protein and protein-lipid interactions, presents a significant challenge for drug development aimed at precise cellular entry control.
Inhibition of clathrin-coated pit formation, dynamin-dependent vesicle scission, or macropinocytosis to prevent cellular entry of pathogens or therapeutic cargos.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell membrane and endocytic uptake machinery.